Supply Chain Planning Takes on An International Flavor
WAM Systems and Ortems link up for joint IT solutions
Eurand Scores With Orally-Disintegrating Form Of GSK's Lamictal
FDA approves new formulation based on bioequivalency with existing product
3M Drug Delivery Expands Inhaler Options
Carrier tapes deliver precise dosages that can be pure API; canister technology improves pressurized dose delivery
Rx-360, a Global Anti-Counterfeiting Consortium, Gains Momentum
Coverage -- Access: Pharma Must Play Activist Role in Health Reform Efforts
Private and public sectors can collaborate to achieve meaningful reform
Psychoactive Drugs: Getting the Whole Support Team on Board
More so than other classes of drugs, making choices about drugs for mental health conditions require everyone around the patient to be well informed
Interest Grows in Handling Physicians' Samples Electronically
While storm clouds gather over pharma sales activities, marketers look to e-sampling as a potential alternative
Global Pharma Sales Growth Will Flatten to 2.5-3.5% in 2009
US market will enter negative growth this year, says IMS Health
Riding the Biotech Financing Rollercoaster
Rx-to-OTC Switch Market Will Double Its Recent Growth Rate
A 3.8% CAGR will rise to 8.0% for 2009-2013, says Kalorama Information
Continental Cargo Approves Use Of AcuTemp Active-Refrigeration Container for Cold Chain Shipping
AcuTemp remains the only FAA-approved container for domestic US use
'Ten Cities Challenge' Diabetes Education Program Publishes Positive Results
Medical and economic results from Diabetes Ten City Challenge show significant benefits in patient health, lower healthcare costs—and higher pharmaceutical usage
Advocates of Diagnostic Testing for Personalized Medicine Press HHS for a Regulatory Framework
Personalized medicine is still more a potential than a reality
Smith Drug Co. Opens a Third Distribution Center
New Valdosta, GA, facility is targeted at independent pharmacies in the Southeast
The Shape of the Electronic Medical Record Market
War-gaming analyst picks the drug distributor over Microsoft, Allscripts and other EMR players
Pharma Gift, Marketing and Advertising Reporting Rules Multiply
States pile on rules; industry wishes for consistency
Contract administration is still 'mediocre to weak' among the majority of biopharma companies, says survey
Model N’s annual analysis of commercial operations finds lost revenue and a lack of IT tools
Workforce and Supply Chain Top Location Must-Have Lists for Biopharma
States continue to push for a ‘bio-economic’ foundation
Drug Wholesalers and the Generic Price War
Reshaping Biotechnology's Financing Relay Race
The current economic downturn may fuel the creation of new, more sustainable business models
Comparative Effectiveness: Tools, Not Rules
Fine-Tuning Specialty Distribution
Specialty manufacturers have a range of options to consider in how to go to market
Momentum Builds in Vaccine Development
Spurred by some recent successful launches, and with hefty R&D funding commitments, the vaccine business is booming
Reverse Logistics Service Providers Deal with Safety and Environment
Sustainability initiatives add to the complexity of managing reverse logistics for life sciences products
Economic Considerations For REMS
Drug sponsors have options in both how the new FDA risk programs are structured and how to execute them
More tools for evaluating DTC advertising
As direct-to-consumer advertising declines, vendors offer tactical aids to marketers
NanoGuardian closes loop with SDI for anticounterfeit protection
Supply-chain monitoring program to be run by healthcare-analytics company
Pfizer pushes generics worldwide
Deals illustrate big pharma’s growing reliance on formerly eschewed market sectors